Matches in Nanopublications for { ?s ?p "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP317483.RAtHbR29j_9gf5wSiHW6AZSWcwFIR1dnSMVZ1CM2SSbPA130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317483.RAtHbR29j_9gf5wSiHW6AZSWcwFIR1dnSMVZ1CM2SSbPA130_provenance.
- NP400113.RAVbgdeK5u_BR3Hamaq9KDm1ET9kW7lw2N6tImQiyG5IM130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP400113.RAVbgdeK5u_BR3Hamaq9KDm1ET9kW7lw2N6tImQiyG5IM130_provenance.
- NP459866.RAtVjbiFzQVQzyjpiPQ2874dGI_5-JA9DBo-Iujh9C2Gc130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459866.RAtVjbiFzQVQzyjpiPQ2874dGI_5-JA9DBo-Iujh9C2Gc130_provenance.
- NP600227.RAmdKbB4NLmZHqz4b6NpMvm-RC_DW1ZueA1kk8liqOOFs130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP600227.RAmdKbB4NLmZHqz4b6NpMvm-RC_DW1ZueA1kk8liqOOFs130_provenance.
- assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779283.RA9ncbcbnvC3tC0QngCd_nqcLtl6DrsxPcu-Jeij269nM130_provenance.
- assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP317041.RAv495APeAI8bq2ROGunXzNr5r8fPzGr5DT31SyPw9rMs130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317041.RAv495APeAI8bq2ROGunXzNr5r8fPzGr5DT31SyPw9rMs130_provenance.
- NP715560.RAREhaPnK6-LqLbGX0pyZ3Ft8ohI-yxPCFeJ_tRP6YQJg130_assertion description "[We show, in both human pancreatic adenocarcinoma and a murine pancreatic tumor model (Pan02), that tumor cells produce increased levels of ligands for the CCR5 chemokine receptor and, reciprocally, that CD4(+) Foxp3(+) Tregs, compared with CD4(+) Foxp3(-) effector T cells, preferentially express CCR5.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715560.RAREhaPnK6-LqLbGX0pyZ3Ft8ohI-yxPCFeJ_tRP6YQJg130_provenance.